(Q37400844)

20 August 2017

Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence (English)

1 reference

20 August 2017

1 reference

1 reference

Helen Marie Pettinati

4

object named as

Helen M Pettinati

1 reference

20 August 2017

Jennifer G Plebani

1

1 reference

20 August 2017

Kevin G Lynch

2

1 reference

20 August 2017

Lior Rennert

3

1 reference

20 August 2017

Charles P O'Brien

5

1 reference

20 August 2017

Kyle M Kampman

6

1 reference

20 August 2017

31 July 2013

1 reference

Drug and Alcohol Dependence

20 August 2017

1 reference

20 August 2017

133

1 reference

20 August 2017

2

1 reference

20 August 2017

754-758

1 reference

Varenicline reduces alcohol self-administration in heavy-drinking smokers

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

Neurochemical and behavioral studies on ethanol and nicotine interactions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

The assessment of anxiety states by rating

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

Development of a Rating Scale for Primary Depressive Illness

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

The Fifth Edition of the Addiction Severity Index

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

Psychometric properties of the Penn Alcohol Craving Scale.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3866905

New weapon to curb smoking: no more excuses to delay treatment

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23916324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23916324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23916324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.DRUGALCDEP.2013.06.019

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

23916324

1 reference